NCT03070392 2026-03-17
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Immunocore Ltd
Phase 2 Completed
Immunocore Ltd
Aura Biosciences
Bellicum Pharmaceuticals
Immunocore Ltd
Pfizer
Bristol-Myers Squibb
Iconic Therapeutics, Inc.
Array BioPharma